Journal article
Antibody levels and protection after hepatitis B vaccine: Results of a 30-year follow-up study and response to a booster dose
Based on anti-HBs level ≥10 mIU/mL at 30 years and an 88% booster dose response, the researchers estimate that ≥90% of participants had evidence of protection 30 years later. Booster doses are not needed.
Authors
Languages
- English
Publication year
2016
Journal
J Infect Dis.
Type
Categories
Diseases
Countries
WHO Regions
